Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients

Gastrointestinal Endoscopy

Volumn 71, Issue 6, 2010, Pages 927-933

  Forlano, Rosario ^a   Ippolito, Antonio Massimo ^a   Iacobellis, Angelo ^a   Merla, Antonio ^a   Valvano, Maria Rosa ^a   Niro, Grazia ^a   Annese, Vito ^a   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BALLOON; BODY MASS; CLINICAL ASSESSMENT; CLINICAL TRIAL; DEVICE REMOVAL; DIET; DISEASE SEVERITY; EXERCISE; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULINEMIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NAUSEA; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFLUX ESOPHAGITIS; TREATMENT OUTCOME; VOMITING; WEIGHT REDUCTION;

ADULT; FATTY LIVER; FEMALE; GASTRIC BALLOON; GASTROPLASTY; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 77951623680     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.06.036     Document Type: Article

References (20)

1. Flegal K.M. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 86 (2005) 599-602
2. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
3. Weintaub M. Long-term weight control: the National Heart, Lung, Blood Institute funded multimodal intervention study. Clin Pharmacol 51 Suppl (1992) 581-646
4. Rucker D., Padwal R., Li S.K., et al. Long term pharmacotherapy for obesity and overweight: update and meta-analysis. Br Med J 335 (2007) 1194-1199
5. Steinbrook R. Surgery for severe obesity. N Engl J Med 350 (2004) 1075-1079
6. Sjöström M.D., Narbro K., David C., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357 (2007) 741-752
7. National Institute of Health Conference. Gastrointestinal surgery for severe obesity. Consensus development conference panel. Ann Intern Med 115 (1991) 956-961
8. Mathus-Vliegen E.M., and Tytgat G.N. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 61 (2005) 19-27
9. Imaz I., Martinez-Cervell C., Garcia-Alvarez E.E., et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg 18 (2008) 841-846
10. Adams R.J., Appleton S., Wilson D.H., et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 28 (2005) 2777-2779
11. Palmentieri B., de Sio I., La Mura V., et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 38 (2006) 485-489
12. Sanford N.L., Walsh P., Matis C., et al. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?. Gastroenterology 89 (1985) 186-191
13. Saverymuttu S.H., Joseph A.E., and Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292 (1986) 13-15
14. Ammar K., Kors J., Yawn B., et al. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am Heart J 148 (2006) 277-284
15. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002) 393-403
16. Fernandes M., Atallah A.N., Soares B.G.O., et al. Intragastric ballon for obesity. Cochrane Database Syst Rev 24 1 (2007) CD004931
17. Norris S.L., Zhang X., Avenell A., et al. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med 117 (2004) 762-774
18. Hamdy O., Porramatikul S., and Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2 (2006) 367-373
19. Sharma A.M. The value of current interventions for obesity. Nat Clin Pract Cardiovasc Med 5 Suppl 1 (2008) S3-S29
20. Herve J., Wahlen C.H., Schaeken A., et al. What becomes of patients one year after the intragastric balloon has been removed?. Obes Surg 15 (2005) 864-870